Proteomic atlas of T cell exhaustion defines proteostatic collapse.
Understanding why cancer-fighting T cells become exhausted reveals a new protein (RNF166) that, when boosted, restores their persistence in early models.
This Cell paper constructs a comprehensive proteomic atlas of T cell exhaustion, identifying widespread proteostatic collapse—including dysfunction of the ubiquitin-proteasome system—as a central regulatory mechanism. E3 ligase RNF166 overexpression improved T cell persistence in preclinical models, offering a new avenue for enhancing cancer immunotherapy efficacy.
What the study was
- Study design
- Multi-omic laboratory study (transcriptomics, quantitative proteomics, turnover proteomics, ubiquitin proteomics) with in vitro and in vivo (mouse) validation; correlates E3 ligase expression with human immunotherapy outcomes
- Population
- T cell exhaustion model (mouse in vivo, human transcriptomic correlation with immunotherapy outcomes)
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Cell
Why it surfaced
High-quality Cell paper providing first comprehensive multi-omic atlas of T cell exhaustion with mechanistic insight into proteostatic collapse; identifies RNF166 as an actionable target for immunotherapy enhancement, but clinical translation is still preclinical.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.